Health news
EU holds firm on pharma reform proposal despite industry pressure
The European Commission has no plans to withdraw or revise its proposed overhaul of EU pharmaceutical rules, despite mounting pressure from the pharmaceutical industry concerned about potential tariffs and the sector’s competitiveness.
ADVERTISEMENT
Markets
Novo Nordisk shares post the biggest monthly decline since 2002
Novo Nordisk’s stocks experienced the sharpest monthly decline since July 2002 due to growing competition and several disappointing trial results. However, analysts remain optimistic about the shares, forecasting a potential price upside of up to 60% over the next 12 months.
Health news
Commission playing catch up with US, China in life science sector
Gene therapies, multi-country clinical trials, and AI-driven personalised medicine are some of the priorities the EU executive is working on for the upcoming Life science strategy, according to details shared with member states.
Health news
EU’s medicine stockpiling challenged by national security concerns
The European Union’s efforts to build a medical stockpile and strengthen health crisis preparedness face a major challenge: a blind spot over national reserves. Many member states are reluctant to share information due to security concerns.
